ES2151502T3 - Complejos quelato y procedimientos para su obtencion. - Google Patents

Complejos quelato y procedimientos para su obtencion.

Info

Publication number
ES2151502T3
ES2151502T3 ES93810100T ES93810100T ES2151502T3 ES 2151502 T3 ES2151502 T3 ES 2151502T3 ES 93810100 T ES93810100 T ES 93810100T ES 93810100 T ES93810100 T ES 93810100T ES 2151502 T3 ES2151502 T3 ES 2151502T3
Authority
ES
Spain
Prior art keywords
complexes
chelato
procedures
obtaining
rutenio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93810100T
Other languages
English (en)
Inventor
Hans Georg Dr Capraro
Marcus Dr Baumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2151502T3 publication Critical patent/ES2151502T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06Aluminium compounds
    • C07F5/069Aluminium compounds without C-aluminium linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046Ruthenium compounds
    • C07F15/0053Ruthenium compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/003Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0834Compounds having one or more O-Si linkage
    • C07F7/0836Compounds with one or more Si-OH or Si-O-metal linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyethers (AREA)

Abstract

SE DESCRIBEN COMPLEJOS QUELATO MULA I, DONDE M COMO ATOMO CENTRAL ES ALUMINIO, GALIO, INDIO, CINC, RUTENIO O DE FORMA PREFERENTE GERMANIO Y DONDE LOS SIMBOLOS RESTANTES SON DEFINIDOS COMO EN LA SOLICITUD DE PATENTE 1. LOS COMPLEJOS PUEDEN SER UTILIZADOS ENTRE OTRAS APLICACIONES PARA LA QUIMIOTERAPIA FOTODINAMICA DE TUMORES.
ES93810100T 1992-02-27 1993-02-18 Complejos quelato y procedimientos para su obtencion. Expired - Lifetime ES2151502T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH60092 1992-02-27

Publications (1)

Publication Number Publication Date
ES2151502T3 true ES2151502T3 (es) 2001-01-01

Family

ID=4190744

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93810100T Expired - Lifetime ES2151502T3 (es) 1992-02-27 1993-02-18 Complejos quelato y procedimientos para su obtencion.

Country Status (22)

Country Link
US (3) US5358940A (es)
EP (1) EP0558449B1 (es)
JP (1) JPH0656839A (es)
KR (1) KR100270284B1 (es)
CN (1) CN1044476C (es)
AT (1) ATE196143T1 (es)
AU (1) AU662800B2 (es)
CA (1) CA2090772A1 (es)
DE (1) DE59310096D1 (es)
DK (1) DK0558449T3 (es)
ES (1) ES2151502T3 (es)
FI (1) FI930831A (es)
GR (1) GR3034887T3 (es)
HU (1) HUT64075A (es)
IL (1) IL104874A (es)
MX (1) MX9301083A (es)
NO (1) NO930719L (es)
NZ (1) NZ247000A (es)
PT (1) PT558449E (es)
SG (1) SG49615A1 (es)
TW (1) TW235298B (es)
ZA (1) ZA931382B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484778C1 (en) * 1990-07-17 2001-05-08 Univ Cleveland Hospitals Phthalocynine photosensitizers for photodynamic therapy and methods for their use
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
GB9123814D0 (en) * 1991-11-08 1992-01-02 Johnson Matthey Plc Photosensitizers
TW235298B (es) * 1992-02-27 1994-12-01 Ciba Geigy
GB9405970D0 (en) * 1994-03-25 1994-05-11 Secr Defence Substituted phthalocyanines
RU2106146C1 (ru) * 1995-07-17 1998-03-10 Институт элементоорганических соединений РАН Средство для подавления опухолевого роста
US5763602A (en) * 1996-10-01 1998-06-09 Li; Ying-Syi Methods of syntheses of phthalocyanine compounds
US5872248A (en) * 1997-03-28 1999-02-16 Case Western Reserve University Methods for inserting silicon into phthalocyanines and naphthalocyanines
IL121440A0 (en) 1997-07-31 1998-01-04 Yeda Res & Dev The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
US6645928B1 (en) * 1999-03-05 2003-11-11 Case Western Reserve University Hydrophobic liquid photobleaches
US8211883B2 (en) * 2004-04-01 2012-07-03 Case Western Reserve University Topical delivery of phthalocyanines
US7153956B2 (en) * 2004-08-09 2006-12-26 Silverbrook Research Pty Ltd Cyanine dye having multifunctional peripheral groups
JP2010163473A (ja) * 2009-01-13 2010-07-29 Konica Minolta Business Technologies Inc インクジェット記録用シアンインク
US8440641B2 (en) * 2009-03-20 2013-05-14 Case Western Reserve University Phthalocyanine salt formulations
RU2682674C2 (ru) 2013-03-15 2019-03-20 Шерри Энн МАКФАРЛЭНД Координационные комплексы на основе металлов в качестве фотодинамических соединений и их применение
WO2019188118A1 (ja) * 2018-03-29 2019-10-03 パナソニックIpマネジメント株式会社 組成物、光電変換素子および撮像装置
JP6767695B2 (ja) 2018-03-29 2020-10-14 パナソニックIpマネジメント株式会社 組成物、近赤外光電変換素子および撮像装置

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3094536A (en) * 1961-01-03 1963-06-18 Malcolm E Kenney Silicon phthalocyanines
US3094535A (en) * 1961-01-03 1963-06-18 Malcolm E Kenney Germanium phthalocyanines
CA1337194C (en) * 1988-04-07 1995-10-03 Koichi Kamijima Tetraazaporphin, process for producing the same, as well as optical recording media using the same and production processes thereof
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
DE3829851A1 (de) * 1988-09-02 1990-03-08 Basf Ag Tetraazaporphyrine sowie strahlungsempfindliche beschichtungsfilme
US5457195A (en) * 1989-12-21 1995-10-10 Board Of Regents, The University Of Texas System Sapphyrin derivatives and conjugates
IL97681A (en) * 1990-04-03 1996-01-31 Ciba Geigy Ag Liposome preparations containing synthetic lipids, given parenterally
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
EP0528991B1 (en) * 1990-05-15 2001-09-26 Diatron Corporation Detectably labelled marker component comprising a fluorophore moiety , fluorescent probe comprising the marker component and uses thereof.
JP3224538B2 (ja) * 1990-05-15 2001-10-29 ダイアトロン・コーポレイション 蛍光プローブとしての蛍光性ポルフィリン、および蛍光性フタロシアニン―ポリエチレングリコール、ポリオール、およびサッカライド誘導体
US5166197A (en) * 1990-07-17 1992-11-24 Kenney Malcolm E Phthalocyanine photosensitizers for photodynamic therapy
WO1992001689A1 (en) * 1990-07-23 1992-02-06 Nippon Oil And Fats Co., Ltd. Perfluoroalkylated naphthalocyanine derivative, production thereof, and optical recording medium
GB9123814D0 (en) * 1991-11-08 1992-01-02 Johnson Matthey Plc Photosensitizers
TW235298B (es) * 1992-02-27 1994-12-01 Ciba Geigy

Also Published As

Publication number Publication date
FI930831A (fi) 1993-08-28
MX9301083A (es) 1993-09-01
JPH0656839A (ja) 1994-03-01
ATE196143T1 (de) 2000-09-15
AU662800B2 (en) 1995-09-14
EP0558449B1 (de) 2000-09-06
US5358940A (en) 1994-10-25
GR3034887T3 (en) 2001-02-28
IL104874A0 (en) 1993-06-10
NZ247000A (en) 1995-07-26
IL104874A (en) 1998-06-15
PT558449E (pt) 2001-02-28
CN1044476C (zh) 1999-08-04
ZA931382B (en) 1993-08-31
DK0558449T3 (da) 2001-01-02
AU3376893A (en) 1993-09-02
CN1075966A (zh) 1993-09-08
CA2090772A1 (en) 1993-08-28
NO930719D0 (no) 1993-02-26
HUT64075A (en) 1993-11-29
NO930719L (no) 1993-08-30
TW235298B (es) 1994-12-01
DE59310096D1 (de) 2000-10-12
US5686439A (en) 1997-11-11
EP0558449A1 (de) 1993-09-01
HU9300554D0 (en) 1993-05-28
KR930017912A (ko) 1993-09-20
KR100270284B1 (ko) 2000-10-16
FI930831A0 (fi) 1993-02-24
US5670491A (en) 1997-09-23
SG49615A1 (en) 2001-01-16

Similar Documents

Publication Publication Date Title
ES2151502T3 (es) Complejos quelato y procedimientos para su obtencion.
DE9290018U1 (de) 2,4-Diaminochinazolin-Derivate zur Verbesserung der Antitumor-Aktivität
DE9190155U1 (de) Chinazolinderivate zur Steigerung der Antitumoraktivität
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
ATA769376A (de) Boeschungssicherungsanordnung fuer die boeschung von daemmen, gelaendeeinschnitten und dgl.
IT1108761B (it) Composizione e procedimento per migliorare le caratteristiche di lavorabilita di poliesteri
IT1126452B (it) Testa di estrusione per profilati per infissi e simili,nonche' profilato ottenuto
ATE233274T1 (de) Oxyiminopregnancarbolactone
ES2197500T3 (es) Uso de cloruro de n,n-bis(fenilcarbamoilmetil)dimetilamonio y sus usos derivados en el tratamiento del dolor cronico.
SE7613588L (sv) Forfarande for framstellning av 3,4-dihydro-kinazolinderivat
ES523661A0 (es) Procedimiento para preparar fenoxipiridinas sulfuro-sustituidas teniendo actividad antiviral. desglose de la patente n 514.940.
SE8006294L (sv) 8-aminoalkyl-4-alkylpsoralener
IT7851802A0 (it) Mento per la relativa fabbricazione perfezionamento nelle lampade per illuminazione subacquea e procedi
DD136751A5 (de) Chromquelle fuer das elektroplattieren,ihre herstellung und verwendung
ES2166900T3 (es) Derivados de ara-c.
MX9201763A (es) Derivados de pirimidina para aumentar la actividad antitumores.
ATE149498T1 (de) Radicicol-derivate, ihre herstellung und ihre antitumorwirkung
ES467189A1 (es) Un procedimiento para la preparacion de nuevas pirroloquino-xalinonas y pirrolobenzodiazepinonas
FI830207L (fi) Pantenolderivat
IT1063073B (it) Utensile da taglio e relativo procedimento per aumentare la resistenza all'usura
FR2319364A1 (fr) Nouvelles diamino-2,4 (p-aminobenzyl)-5 pyrimidines, utiles notamment comme agents antibacteriens
IT966750B (it) 2,2 bis oppure 2,2,2 tris 5,6 diidro 4h i,3 ossazine e procedimento per produrle
IT1075223B (it) Perfezionamento nelle disposizioni di lampada di ingombro e seganlazione per autoveicoli
NO870398D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive organiskeplatinakomplekser.
NL7703423A (nl) Kristaloscillator met een laag energieverbruik.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 558449

Country of ref document: ES